Both collagenase-3 and osteocalcin mRNAs are expressed maximally during the later stages of osteoblast differentiation. Here, we demonstrate that collagenase-3 mRNA expression in differentiating MC3T3-E1 cells is dependent upon the presence of ascorbic acid, is inhibited in the presence of the collagen synthesis inhibitor, 3,4-dehydroproline, and is stimulated by growth on collagen in the absence of ascorbic acid. Transient transfection studies show that collagenase-3 promoter activity increases during cell differentiation and requires the presence of ascorbic acid. Additionally, we show that, in differentiating MC3T3-E1 cells, collagenase-3 gene expression increases in the presence of an anti-osteopontin monoclonal antibody that binds near the RGD motif of this protein, whereas osteocalcin expression is inhibited. Furthermore, an RGD peptidomimetic compound, designed to block interaction of ligands to the ␣ v integrin subunit, increases osteocalcin expression and inhibits collagenase-3 expression, suggesting that the RGD peptidomimetic initiates certain ␣ v integrin signaling in osteoblastic cells. Overall, these studies demonstrate that stimulation of collagenase-3 expression during osteoblast differentiation requires synthesis of a collagenous matrix and that osteopontin and ␣ v integrins exert divergent regulation of collagenase-3 and osteocalcin expression during osteoblast differentiation.
When primary or clonal osteoblastic cells, such as MC3T3-E1 cells, are cultured with ␤-glycerophosphate (␤-gly) 1 and ascorbic acid (AA), the cells undergo a differentiation process and eventually produce bone nodules resembling woven bone in vitro (1) (2) (3) (4) . Mineral deposition occurs in the final stages of osteoblast differentiation and is associated with maximal osteoblastic expression of osteocalcin and collagenase-3 (5-7). The mechanisms controlling osteoblast differentiation are unclear, but research suggests that a reciprocal interaction exists between the osteoblast and the surrounding extracellular matrix. For example, when osteoblasts or osteoblast-like cells are grown on plates pre-coated with collagen, they exhibit early signs of osteoblast maturation and osteoblastic gene expression (8 -12) . Further accumulating data suggest that the extracellular matrix mediates many effects through activation of integrin signaling pathways in osteoblasts (12) (13) (14) . Osteoblasts and osteoblast-like cells have been reported to express a wide variety of integrin receptor subunits, including ␣ 1 , ␣ 2 , ␣ 3 , ␣ 4 , ␣ 5 , ␣ v , ␤ 1 , and ␤ 3 (15) (16) (17) .
Osteocalcin (OC), or bone gla protein, is a calcium-binding protein found in bone extracellular matrix and expressed by osteoblasts, odontoblasts, and hypertrophic chondrocytes (reviewed in Ref. 18 ). It has an affinity for hydroxyapatite, suggesting a role in the regulation of mineralization. In fact, OCnull mutant mice exhibit increased bone density (19) , although defects in mineralization have been detected (20) . Recent evidence suggests that the up-regulation of OC late in osteoblast differentiation is dependent upon collagen-integrin interaction. For example, the presence of AA dramatically increases the expression of OC and its promoter activity (21) . Conversely, incorporation of proline analogs, such as 3,4-dehydroproline (DHP), by osteoblasts, or the presence of ␣ 2 integrin blocking antibodies, prevents the induction of OC expression (14, 21, 22) . Interestingly, a runt domain binding site (RD) located in the OC promoter is required for AA responsiveness. Furthermore, RUNX2/Cbfa1, a runt domain binding transcription factor found in osteoblasts, is activated by MEK and leads to increased OC expression during differentiation of clonal mouse calvarial cells (MC3T3-E1 cells) (21, 23) .
Osteopontin (OPN) is a highly phosphorylated and glycosylated protein found in the extracellular matrix of mineralized tissues and in all body fluids (reviewed in Ref. 24) . OPN interacts with a number of integrins, including ␣ v ␤ 1 , ␣ v ␤ 3 , ␣ v ␤ 5 , ␣ 4 ␤ 1 , ␣ 8 ␤ 1 , and ␣ 9 ␤ 1 . Of these integrins, osteoblasts have been shown to express the ␣ v ␤ 1 , ␣ v ␤ 3 , ␣ v ␤ 5 , ␣ 4 ␤ 1 , and ␣ 8 ␤ 1 integrins, at least in culture (15) (16) (17) (25) (26) (27) (28) . Mice lacking OPN develop essentially normal skeletal tissues but are protected against ovariectomy-induced bone loss (29, 30) . This result suggests that bone lacking OPN is less readily remodeled. In fact, high levels of OPN are found in areas of bone remodeling (31) , and OPN has been shown to colocalize with the osteoclast ␣ v ␤ 3 integrin (32) . The ␣ v ␤ 3 integrin has been shown to be essential in mediating the resorptive activity of osteoclasts in bone (33) (34) (35) , and peptidomimetic antagonists of the ␣ v ␤ 3 integrin have been shown to prevent osteoporosis in ovariectomized rats (36) .
Collagenase-3 belongs to the family of matrix metalloproteinases (MMPs), which are responsible for degrading components of the extracellular matrix (reviewed in Ref. 37) . Three types of collagenases have been identified in humans, and murine homologs of all three have been identified (38 -40) . In murine models, only collagenase-3 has been shown to play a significant role in bone. In skeletal tissue, matrix degradation by collagenase-3 has been associated with bone remodeling, endochondral bone formation, bone repair, and parathyroid hormone (PTH)-induced bone resorption (41) (42) (43) (44) (45) . The role of collagenases in bone degradation is further evidenced by the finding that homozygous mutation of the collagenase cleavage site in the Col1a1 gene in mutant mice results in diminished PTH-induced bone resorption, diminished PTH-induced calcemic responses, and thicker bones (46) . Collagenase-3 is synthesized by a variety of cells, but in normal skeletal tissue it is expressed mainly by the matrix-forming cells, the osteoblasts and osteocytes in bone, and hypertrophic chondrocytes in cartilage (44, 47, 48) . Like most other matrix metalloproteinases, collagenase-3 is regulated at the level of transcription (7, 49 -51) . For example, PTH stimulates collagenase-3 gene expression in osteoblastic cells and requires the activator protein-1 (AP-1) and RD binding regions found just upstream of the collagenase-3 transcriptional start site (52, 53) . Similar to OC, collagenase-3 gene expression increases during differentiation (6, 54) and is transcriptionally regulated during this process (6) . Given that collagenase-3 and OC are expressed during similar periods of osteoblast differentiation and that expression of both genes is regulated by RUNX2/Cbfa1, it seems reasonable to hypothesize that collagenase-3, like OC, is also regulated by integrin interaction with the extracellular matrix.
Here, we demonstrate that stimulation of collagenase-3 expression during osteoblast differentiation requires the presence of a collagenous matrix. Additionally, we demonstrate that collagenase-3 promoter activity is induced during osteoblastic differentiation and requires ascorbic acid supplementation. Finally, we provide evidence that demonstrates divergent regulation of collagenase-3 and OC by OPN and ␣ v integrins.
EXPERIMENTAL PROCEDURES
Reagents-The 3,4-dehydroproline, ␤-gly, AA, mixed xylenes, n-butyryl coenzyme A, and normal mouse IgG control for OPN antibodies were purchased from Sigma Chemical Co. (St. Louis, MO). Type I collagen was purchased from Upstate Biotechnology (Lake Placid, NY). The AA-free ␣-MEM was obtained from Washington University Tissue Culture Center (St. Louis, MO). All other tissue culture media were obtained from Invitrogen (Rockville, MD). The ␣ v integrin antagonist, RGD peptidomimetic compound (SC65811) was obtained from Searle & Co. (St. Louis, MO) and has previously been described (55) . Radionucleotides were obtained from Amersham Biosciences (Piscataway, NJ).
DNA Constructs-The 148-base pair collagenase-3 promoter construct was previously synthesized in the pSV0CAT chloramphenicol acetyltransferase reporter plasmid (Promega) (53) . The constitutively active control plasmids pSV2 (CAT) and pGL3 (luciferase) and the inactive control plasmid, pSV0, were purchased from Promega Corp. The collagenase-3 probe is the rat cDNA from clone UMRCase54 in pBluescript, which has previously been described (38) . The mouse OPN cDNA is the pGEM-2arcDNA construct, which contains the complete coding region of OPN (56) . The rat OC cDNA is cloned in the pGEM7Zf vector and was generously provided by Dr. Jane Lian (57) . The 18 S ribosomal probe is the LS2 construct containing cDNA for human 18 S ribosomal RNA (58) .
Cell Culture-The MC3T3-E1 cell line (the highly mineralizing subclone 4 cell line) was kindly provided by Dr. Renny Franceschi (University of Michigan, Ann Arbor, MI) (59) . For Northern experiments studying cell differentiation, cells were plated at a density of 6300 cells per cm 2 in AA-free ␣-MEM supplemented with 10% FBS, penicillin (100 units/ml), and streptomycin (100 g/ml). For transfection experiments, cells were plated at high density, 25,000 cells/cm 2 in the same medium. Upon reaching confluency, the MC3T3-E1 cells were switched to AAfree ␣-MEM containing 10 mM ␤-gly and 50 g/ml AA (mineralizing medium) where indicated. The medium was also supplemented with either 500 M 3,4-dehydroproline (DHP), 6 -24 M integrin blocking antibody, 0.1-10 M RGD peptidomimetic (SC65811), or 240 nM recombinant OPN where indicated. Media changes were performed every 2 or 3 days. Collagen-coated plates were prepared by adding 1.6 ml of collagen solution (4.5 mg/ml), 0.2 ml of FBS, and 0.2 ml of 260 mM NaHCO 3 into each well of a six-well plate and incubating for 1 h at room temperature. Cells and medium were then added, the cells were grown until the plates became confluent, and then cultured in mineralizing medium as described above.
RNA Isolation and Northern Blots-Total RNA was isolated from MC3T3-E1 cells at 1-and 2-week intervals following confluency. RNA (20 g) was fractionated by gel electrophoresis on a 1% agarose, 2.2 M formaldehyde gel in 40 mM MOPS, pH 7.0, 10 mM sodium acetate, 1 mM EDTA running buffer. Gels were then blotted overnight to Zeta-Probe membranes (Bio-Rad, Hercules, CA) and UV cross-linked. Next, the filters were incubated for 1 h at 65°C in prehybridization fluid (0.25 M Na 2 HPO 4 , pH 7.2 and 7% SDS). Fresh prehybridization fluid was then added along with 10 6 cpm/ml of random-primed [␣-32 P]dCTP-labeled cDNA probe and incubated overnight at 65°C. The following day, the filters were washed twice for 30 -60 min each time with 40 mM Na 2 HPO 4 , pH 7.2, and 5% SDS at 65°C, and twice with 40 mM Na 2 HPO 4 , pH 7.2, and 1% SDS at 65°C for 30 -60 min each time. Bound radiolabeled probe was then quantitated using a PhosphorImager and ImageQuaNT software (Amersham Biosciences, Piscataway, NJ). All data were then expressed as the ratio of collagenase-3, osteocalcin, or osteopontin phosphorimaging units to LS2 (18 S ribosomal RNA) phosphorimaging units.
Transfection and CAT Assays-MC3T3-E1 cells were transiently transfected with SuperFect reagent (Qiagen) according to the manufacturer's protocol. Briefly, 1 g of collagenase-3 reporter construct, 1 ng of pGL3 luciferase reporter DNA, and 10 l of SuperFect were added to each well of near-confluent MC3T3-E1 cells in six-well plates. Three hours later, the medium was changed and the cells were cultured for 1 day (confluent cells) and then lysed, or grown in ␤-gly-supplemented or ␤-gly-and AA-supplemented medium for 5 days and then lysed and processed for CAT activity (5 days post-confluent cells). CAT assays were carried out by standard methods as previously described (60) . Briefly, after incubation, cells were washed with phosphate-buffered saline, pH 7.4, and lysed in 150 l of 1ϫ Reporter lysis buffer (Promega, Madison, WI). Next, 50 l of lysate was combined with 23 M 14 Clabeled chloramphenicol (0.125 Ci/assay) and 250 M n-butyryl coenzyme A. The reaction volume was adjusted to 100 l with 250 mM Tris-HCl, pH 8.0, and incubated at 37°C for 2 h. The reaction was terminated by the addition of 200 l of mixed xylenes, and the butylated chloramphenicol in the aqueous phase was pre-extracted to a fresh tube. The xylene phase was back-extracted with 100 l of 250 mM Tris-HCl, pH 8.0, and the final butylated chloramphenicol was quantitated by scintillation counting. All samples were performed in triplicate and normalized to luciferase reporter activity. Luciferase activity was measured in a luminometer using the Luciferase Assay System (Promega).
OPN Antibody Preparation-Antibodies were prepared as described (61) . Briefly, intraperitoneal injections were first made into OPN knockout mice (29) . Approximately 20 g of recombinant histidine-tagged human (or mouse) OPN (prepared in Escherichia coli and purified on a nickel column) in 250 l of PBS mixed with 250 l of Freund's complete adjuvant was injected intraperitoneally. After 2 and 5 weeks, the mice were boosted with an equal amount of protein in Freund's incomplete adjuvant. Three weeks later (week 8) the mice were given a final boost 3 days prior to sacrifice and splenectomy. Spleen cells were fused to SP2/0 cells and selected with hypoxanthine aminopterin thymidine medium. Positive clones were then selected via enzyme-linked immunosorbent assay and Western blots and cloned to single cells with two rounds of limiting dilution cloning.
Monoclonal antibodies were produced from hybridomas grown in Dulbecco's modified Eagle's medium supplemented with 1ϫ hypoxanthine/thymidine, 10% FBS, glutamine, and penicillin/streptomycin. The tissue culture media were collected after incubating the hybridomas for 2 weeks to ensure that the majority of cells had died. The cells were pelleted, and the medium was then applied to an OPN affinity column (GST-fused OPN coupled to Sepharose). Antibodies were eluted with 100 mM glycine-HCl, 0.5 M NaCl, pH 2.7, and immediately neutralized with Tris-HCl to pH 7.0 -7.5. The 2A1 and 2C5 antibodies were raised against mouse OPN, whereas 1G4 was raised against human OPN.
Statistical Analysis-The data in Figs 
RESULTS

Collagenase-3 Expression in Differentiating MC3T3-E1 Cells Is Dependent on AA Supplementation and Is Inhibited by 3,4-
Dehydroproline and ␤-gly-Previously, we had demonstrated that collagenase-3 expression was induced when confluent primary osteoblasts were cultured with AA and ␤-gly (6), but the factors responsible for this regulation were not defined. To first study whether collagenase-3 is regulated by AA or ␤-gly alone, MC3T3-E1 cells were grown to confluence and cultured with AA, ␤-gly, neither, or both together, and the RNA samples were examined by Northern analysis. As demonstrated in Fig. 1A , AA is clearly the agent required for collagenase-3 induction after 2 weeks of culture. The pattern of collagenase-3 expression closely mimicked that of OC (Fig. 1B) . The addition of the inhibitory proline analog, 3,4-dehydroproline (DHP), completely abolished collagenase-3 expression (Fig. 1A ) in the same fashion as for OC (Fig. 1B) . We additionally cultured the MC3T3-E1 cells with antibodies that block the binding of ␣ 2 or ␤ 1 integrin subunits but observed either slightly decreased collagenase-3 gene expression or no effect (data not shown).
Phosphatase substrates, such as ␤-gly, have previously been shown to induce OPN expression in osteoblastic cells (62) . When MC3T3-E1 cells were cultured with ␤-gly alone, OPN mRNA levels increased as expected (Fig. 1C ), but no induction of collagenase-3 expression was seen (Fig. 1A) . In fact, the addition of ␤-gly with AA appeared to slightly decrease collagenase-3 expression. This effect was more apparent in cells cultured for 1 week instead of two (Fig. 2) . OC was relatively unaffected by ␤-gly supplementation (Fig. 1B) . Interestingly, OPN expression was slightly decreased when cultured with AA and ␤-gly compared with ␤-gly alone (Figs. 1C, 3C, 6C ). Overall, collagenase-3 expression, like OC, was induced by AA supplementation and inhibited by the presence of DHP, suggesting that collagen synthesis is required for collagenase-3 induction.
FIG. 1.
Collagenase-3 expression in differentiating MC3T3-E1 cells is dependent on AA supplementation and is inhibited by 3,4-dehydroproline and ␤-gly. MC3T3-E1 cells were grown to confluence, switched to AA-free ␣-MEM supplemented with 10% FBS, and cultured for 2 weeks on uncoated plastic tissue culture dishes. Where indicated, 10 mM ␤-gly, 50 g/ml ascorbic acid, and 500 M of the collagen synthesis inhibitor, 3,4-dehydroproline (DHP), were added. Following the 2-week culture period, the cells were lysed and total RNA was examined by Northern analysis with collagenase-3, OC, OPN, and 18 S ribosomal RNA radiolabeled probes using the same blot. A, collagenase-3 normalized to 18 S ribosomal RNA. *, indicates p Յ 0.002 comparing both bars 2 and 4 to bars 1 and 5. B, OC normalized to 18 S ribosomal RNA. *, p Յ 0.002 comparing both bars 2 and 4 to bars 1 and 5. C, OPN normalized to 18 S ribosomal RNA. *, p Յ 0.03 comparing bar 3 to each of the four other samples in the group. D, autoradiographs of the same samples used for phosphorimaging quantitation: collagenase-3 (CЈase-3), osteocalcin (OC), osteopontin (OPN), and 18 S ribosomal RNA (18S).
Collagenase-3 Expression Is Increased by Culture on Collagen-coated Plates in the Absence of AA-To test whether growth
on collagen could induce collagenase-3 expression, MC3T3-E1 cells were cultured on plastic or on collagen-coated plates until confluent. The cells were then cultured in ␤-gly-supplemented medium for 1 week in the presence (AA) or absence (Ϫ) of AA. In the absence of AA, the collagenase-3 expression increased 2.5-fold when grown on collagen compared with growth on plastic (Fig. 3A) ; although this increase was not nearly as high as when the cells were supplemented with AA alone. Additionally, AA supplementation together with growth on collagen actually inhibited collagenase-3 expression in the MC3T3-E1 cells. Conversely, OC expression was detectable only when cultured with AA and expression was further increased with growth on collagen plates (Fig. 3B ). This result demonstrates that the collagen matrix used in this experiment stimulated osteocalcin expression in osteoblastic cells as previously described (10) .
Many studies have found that OPN expression is induced by mechanical stresses on osteoblasts (63) (64) (65) (66) . To test whether collagenase-3 may respond in a similar fashion as OPN, the collagen matrix was simply detached from the plastic dish, yielding a free floating matrix that was cultured for 24 h before the total RNA was isolated. Under these conditions OPN expression increased 3-fold (Fig. 3C ), but collagenase-3 and OC showed no significant changes (Fig. 3, A and B, respectively) . Interestingly, growth of the MC3T3-E1 cells on collagen inhibited OPN expression more than AA treatment alone, and both together maximally inhibited OPN expression. Thus, collagenase-3 gene expression appears to be stimulated by collagen, but not through a mechanoreceptor, and conversely, OPN gene expression is inhibited by the presence of collagen, except when stimulated in response to activation of a mechanoreceptor.
Collagenase-3 Promoter Activity Increases during Cell Differentiation and Requires AA Supplementation-Previous work has demonstrated that only the 148 base pairs upstream of the collagenase-3 transcriptional start site are required for PTH stimulation of promoter activity in the rat osteoblastic osteosarcoma cell line, UMR 106-01 (53). Additionally, both the activator protein-1 (AP-1) and runt domain (RD) binding sites, located within these 148 base pairs of the collagenase-3 promoter, are required for full activation by PTH (53, 67) . During osteoblast differentiation, the collagenase-3 promoter is transcriptionally regulated, and evidence suggests that the promoter may be regulated by differential control of different AP-1 subunits and the RUNX2/core binding factor alpha 1 (Cbfa1) transcription factor, which binds the RD site (7). To test collagenase-3 promoter activation during osteoblast differentiation, we transiently transfected MC3T3-E1 cells with the 148-base pair collagenase-3 promoter construct along with a constitutively active luciferase reporter construct just prior to reaching confluency. The following day, the cells were lysed or switched to mineralizing medium (AA and ␤-gly supplementation), cultured for 5 days, and then assayed for CAT and normalized to luciferase activity. Similar normalization of CAT activity to luciferase activity was previously performed in MC3T3-E1 cells using the OC promoter (21) . As shown in Fig. 4A , the 148-bp promoter construct (148) of collagenase-3 was stimulated greater than 2-fold after culturing in mineralizing medium for 5 days compared with cells that had just reached confluence. In contrast, the cells transfected with the negative control plasmid (pSV0) showed no change in normalized CAT activity and cells transfected with the positive control plasmid (pSV2) were slightly decreased. MC3T3-E1 cells were then transfected with the 148 collagenase-3 promoter and luciferase construct and cultured in ␤-gly supplemented medium for 5 days in the presence (ϩAA) or absence (Ϫ) of AA. As shown in Fig. 4B , the addition of AA led to a 3.5-fold increase in 148 collagenase-3 promoter activity over culture with ␤-gly alone.
OPN and ␣ v ␤ 3 Integrins Have Significant Effects on OC and Collagenase-3 Expression in Differentiating MC3T3-E1 Cells-As noted in Fig. 2 , MC3T3-E1 cells cultured for 1 week in the presence of ␤-gly and AA exhibited decreased collagenase-3 expression compared with cells cultured with AA alone. Because ␤-gly stimulates osteopontin expression, as shown in this ( Fig. 1 ) and other studies (62), we hypothesized that the decrease in collagenase-3 expression may be related to increased OPN production and increased signaling by this extracellular protein. To test this hypothesis, MC3T3-E1 cells were cultured in mineralizing medium for 2 weeks with several monoclonal antibodies raised against OPN and then examined by Northern analysis. Of the three antibodies tested, only antibody 2C5 binds near the RGD domain of OPN. 2 As shown in Fig. 5 , addition of increasing concentrations of antibody 2C5 led to slightly increased collagenase-3 expression (Fig. 5A) , dramatically inhibited OC expression (Fig. 5B) , and slightly increased OPN expression (Fig. 5C ). Antibodies 1G4 and 2A1 had occasional modest effects on the expression of all three genes compared with the 2C5 antibody, whereas mouse IgG of equal concentrations had no effect on gene expression. Because osteopontin interacts with ␣ v ␤ 3 integrin on osteoclasts, we investigated the influence of this integrin on osteoblastic gene expression. To test the effect of blocking ␣ v integrins, we incubated confluent MC3T3-E1 cells with an ␣ v blocking antibody for 1 week in ␤-gly and AA supplemented medium. As shown in Fig. 6 , the ␣ v blocking antibody increased the expression of collagenase-3 ( Fig. 6A) and OPN (Fig. 6C) , similar to the 2C5 blocking antibody, but increased osteocalcin gene expression (Fig. 6B) . Culturing the cells with the 2C5 anti-OPN antibody again reduced OC levels down to background levels, similar to culture in the absence of AA. MC3T3-E1 cells cul-2 A. J. Kowalski and D. T. Denhardt, manuscript in preparation.
FIG. 2. Collagenase-3 expression in differentiating MC3T3-E1
cells is inhibited by ␤-gly. MC3T3-E1 cells were grown to confluence, switched to AA-free ␣-MEM supplemented with 10% FBS and 50 g/ml AA, and cultured for 1 week in the absence (AA) or presence (ϩ␤-gly) of 10 mM ␤-gly. Following the 1-week culture period, the cells were lysed and total RNA was examined by Northern analysis with collagenase-3 (CЈase-3) and 18 S ribosomal RNA (18S) radiolabeled probes using the same blot. The collagenase-3 mRNA levels were quantitated using phosphorimaging and normalized to 18 S ribosomal levels. *, p ϭ 0.003. tured with recombinant OPN for 1 week in mineralizing conditions demonstrated increased OC expression (Fig. 6B ) but no change in collagenase-3 (Fig. 6A) or OPN (Fig. 6C) expression levels.
Finally, the Arg-Gly-Asp-peptidomimetic compound, SC65811, which was designed to selectively block the interaction of the ␣ v integrin subunit with various extracellular components, including vitronectin, fibrinogen, and OPN, was incubated with the MC3T3-E1 cells during a 1-or 2-week culture period in mineralizing medium. As shown in Fig. 7 , addition of SC65811 during a 1-week mineralizing culture period produced opposite effects compared with the OPN blocking antibody as demonstrated by a decrease in collagenase-3 expression (Fig.  7A ) and a stimulation of OC expression (Fig. 7B) ; however, OPN expression (Fig. 7C) was again stimulated. Furthermore, both OC and OPN dramatically responded to increasing doses of SC65811 during a 2-week mineralizing culture period (Fig. 8,  A and B, respectively) . All of these results are summarized in Table I . DISCUSSION 
Collagen Stimulation of Collagenase-3 Gene Expression-
The initial goal of this study was to characterize the expression of collagenase-3 mRNA during differentiation of the osteoblastic cell line, MC3T3-E1. Noting the similarities between OC and collagenase-3 in both expression and promoter regulation by RUNX2/Cbfa1 and AP-1 factors, we hypothesized that the two genes were similarly regulated by collagen during osteoblast differentiation. As expected, the same collagen synthesis modulators that stimulated OC also stimulated collagenase-3 expression. Ascorbic acid (AA) is required for proline hydroxylation by prolyl hydroxylase and, in the absence of AA, collagen chains cannot properly align to form triple helices and are degraded within the osteoblast (22) . Similarly, incorporation of proline analogs, such as 3,4-dehydroproline, by osteoblasts prevents hydroxylation and collagen synthesis (21, 22, 68) . When deprived of AA or cultured with the collagen synthesis inhibitor 3,4-dehydroproline, collagenase-3 expression was inhibited in FIG. 3 . Stimulation of collagenase-3 expression by MC3T3-E1 cells grown on collagen. MC3T3-E1 cells were plated onto collagen coated-plates, grown to confluency, then switched to ␣-MEM supplemented with 10 mM ␤-gly and 50 g/ml AA as indicated, and cultured for 1 week. Additionally, the collagen matrix for the last sample set was detached from the plate and was free floating for 24 h prior to isolation of RNA. Following the 1-week culture period, all cells were lysed and total RNA was examined by Northern analysis with collagenase-3, OC, OPN, and 18 S ribosomal RNA radiolabeled probes using the same blot. the same manner as OC. The finding that the synthesis of collagen regulates collagenase-3 expression is consistent with other studies demonstrating that many types of matrix metalloproteinases, including collagenases, are regulated by interaction with collagen and extracellular matrix components (reviewed in Ref. 69 ). For example, human skin fibroblasts express collagenase-3 when grown in three-dimensional collagen gels (70) , and the binding of ␣ 2 ␤ 1 integrins to collagen induces collagenase-1 expression in human osteoblastic cells (71) .
Collagenase-3 expression was also stimulated by growth on collagen, but not to the same extent as simply culturing the cells in AA, and was inhibited by the combination of AA and growth on collagen. These findings may be explained by considering that the collagenous matrix formed by the osteoblast is inherently different in structure and in composition to the preformed collagen matrix. Furthermore, this finding may be reflected in whole animal studies. For example, collagen fibrils in woven bone, such as those found in areas of fracture healing, are arranged in many directions and contain wide interfibrillar spaces, whereas fibrils in lamellar bone are more aligned and closely packed (reviewed in Ref. 72) . Interestingly, when whole bone is stained for the presence of collagenase-3, it is found in areas containing woven bone, such as developing bone and areas of fracture healing (73) . Conversely, almost no collagenase-3 is found in normal, adult bone (43) . Thus, the full stimulation of collagenase-3 gene expression may be related to the structure of the osteoblastic synthesized matrix, which resembles the loose structure of woven bone in culture. Additionally, it has been suggested that the larger interfibrillar spaces found in woven bone could accommodate more noncollagenous proteins than bone containing more tightly packed collagen (72) . Extracellular factors such as transforming growth factor-␤, fibronectin, laminin, and bone morphogenetic proteins synthesized by osteoblasts have all been implicated as mediators or essential regulators of osteoblast differentiation and could potentially regulate collagenase-3 expression (12, 74, 75) . Synthesis of such factors and regulated deposition of these factors into the interfibrillar spaces of collagen during the synthesis of the osteoblastic matrix could also contribute to the stimulation of collagenase-3 during osteoblast differentiation. Overall, these results suggest that a collagenous matrix is vital for stimulation of collagenase-3 gene expression during osteoblast differentiation, but it may need to be properly oriented and contain other factors to be sufficient.
Collagenase-3 Promoter Stimulation during MC3T3-E1
Cell Differentiation-Previous nuclear run-on studies had demonstrated that collagenase-3 is transcriptionally regulated during osteoblast differentiation (7) . We further demonstrate here that the collagenase-3 promoter is also activated during MC3T3-E1 differentiation and is dependent on AA. It has been well documented that AP-1 subunits and RUNX/Cbfa proteins are expressed differently during the stages of osteoblast differentiation (reviewed in Ref. 18 ) and that different AP-1 factors bind the AP-1 site in proliferating compared with differentiated osteoblasts (7). The presence of the different levels of AP-1 subunits or RUNX/Cbfa proteins or the increased activation of these proteins could represent a mechanism that initiates collagenase-3 promoter activation during osteoblast differentiation.
The Role of Osteopontin in Regulating Gene Expression in Differentiating MC3T3-E1 Cells-Similar to osteocalcin gene expression, AA and collagen synthesis were clearly required for collagenase-3 gene expression in differentiating MC3T3-E1 cells. Conversely, collagenase-3 gene expression was not regulated in any manner similar to OPN; ␤-gly supplementation appeared to have inhibitory effects and mechano-stimulation by collagen detachment had no effect. Both of these stimuli enhanced OPN gene expression, and collagen appeared to inhibit OPN gene expression. Although regulation of collagenase-3 and OPN gene expression are clearly different, evidence presented here suggests that OPN negatively regulates collagenase-3 gene expression. Collagenase-3 gene expression increased when cultured with both OPN-blocking antibodies and ␣ v -blocking antibodies. Interestingly, the RGD peptidomimetic compound, SC65811, designed to prevent interaction of ligands FIG. 4 . The collagenase-3 promoter is up-regulated 5 days postconfluency and requires AA supplementation. A, just prior to reaching confluency, MC3T3-E1 cells were transfected with the pGL3 luciferase reporter plasmid and the 148 collagenase-3 promoter-CAT construct, the negative control plasmid (pSV0), or the pSV2 positive control plasmid (inset) and lysed the following day (confluent) or cultured for 5 additional days in medium supplemented with 10 mM ␤-gly and 50 g/ml AA. All samples were then assayed for CAT activity and normalized to luciferase activity. *, p Ͻ 0.001 comparing the 148-CAT 5-day post-confluency data to the 148-CAT confluent data. B, MC3T3-E1 cells were transfected with the pGL3 luciferase reporter plasmid and the 148 construct just prior to reaching confluency and cultured for 5 days in medium supplemented with 10 mM ␤-gly in the absence (Ϫ) or presence of 50 g/ml AA (ϩAA). The samples were then lysed, assayed for CAT activity, and normalized to luciferase activity. *, p ϭ 0.008.
with the ␣ v integrin subunit, produced the opposite effect of the OPN antibody (2C5) and decreased collagenase-3 expression (summarized in Table I ).
OPN is a secreted molecule found both in a soluble form and associated with calcified extracellular matrices. The ␣ v integrin subunit belongs to a family of membrane-associated molecules capable of controlling several cell signaling pathways (reviewed in Ref. 76) . Although the interaction of an antibody with OPN would not be expected to directly initiate cell signaling, because OPN is not a membrane-signaling molecule, the interaction of an ␣ v integrin-blocking peptide with the ␣ v integrin could potentially modulate the signaling mechanisms initiated by the ␣ v receptor. It is possible that SC65811 modulates such signals from ␣ v integrins. In other words, the RGD peptidomimetic could block receptor and OPN interaction by competing for ␣ v integrin subunits, but, upon interaction with the integrin, it could activate similar signaling pathways as OPN or could activate completely separate signaling pathways. Such a scenario does not conflict with previous findings with RGD peptidomimetic compounds. Although RGD peptidomimetic compounds have been previously shown to block osteoclast adhesion to bone (35) , compound SC65811 has recently been shown to inhibit binding of osteoclasts to OPN and vitronectin, but not to bone (except at elevated concentrations), although it still inhibited osteoclastic bone resorptive activity (55). Carron et al. (55) explain that SC65811 may mediate its anti-resorptive effects by influencing the cell signaling of the ␣ v ␤ 3 integrins and lead to changes in migration of the osteoclast. In this fashion, SC65811 would act as an initiator of cell signaling, in addition to blocking the binding of osteopontin to osteoclasts. This hypothesis is further supported by the finding that ␣ v ␤ 3 integrins change to a second "active" conformational state when bound to OPN and that this receptor conformation stimulates adhesion and migration of the osteoclast (77) . Similar signaling mechanisms could be initiated in osteoblasts upon interaction of the ␣ v ␤ 3 integrin with the RGD peptidomimetic, and such mechanisms could be related to the signaling pathways initiated by OPN.
In contrast to enhancing collagenase-3 gene expression, the OPN-blocking antibody 2C5 inhibited OC gene expression, and correspondingly, SC65811 had the exact opposite effect and stimulated OC gene expression. Thus it appears that OC gene expression is stimulated by OPN. In support of this finding, recombinant OPN also increased OC gene expression. The effects of OPN self-regulation were less clear. Almost all the blocking agents increased OPN gene expression, which suggests that any perturbation of the interaction between OPN and ␣ v integrin subunits stimulates OPN gene expression.
Although, overall, it appears that OPN stimulates expression of osteocalcin and inhibits expression of collagenase-3, several incongruities were noted. For example, culturing with recombinant OPN had no effect on either collagenase-3 or OPN gene expression. It should be noted, however, that recombinant, bacterially synthesized, OPN lacks the post-translational modifications (phosphorylation, glycosylation) found in OPN synthesized by mammalian cells. Such post-translational modifications could greatly influence the interaction of OPN with its receptors. Of all three genes, osteocalcin showed the greatest changes in expression in response to the different blocking agents and may be a more sensitive target for OPN. Thus, the recombinant OPN may have been able to trigger detectable responses in OC but not the other genes. In contrast to the effects on OPN and collagenase-3, the ␣ v blocking antibody increased the expression of OC instead of inhibiting it. This finding may also be related to the ability of the antibody to activate receptor signaling or may be related to receptor dynamics. For example, the ␣ v blocking antibody may influence the interaction of ligand with ␣ v integrin receptors, other than the ␣ v ␤ 3 integrin, which may also influence OC gene expression. In addition to OPN, several factors in the extracellular matrix of osteoblasts also have the ability to interact with the ␣ v ␤ 3 integrin, including vitronectin, laminin, fibronectin, and bone sialoprotein (16, 78 -82) . Likewise, OPN interacts with several integrins, including ferent sites on the ␣ v integrin compared with compound SC65811, which could then lead to different influences on the cell signaling processes of the integrin receptors.
Overall, there is clearly a correlation between OPN/␣ v integrins and the regulation of collagenase-3 and OC gene expression during MC3T3-E1 differentiation. When OPN/receptor interaction is blocked, collagenase-3 gene expression is stimulated and OC expression is inhibited. Whether SC65811 or the ␣ v blocking antibody activates or simply blocks the ␣ v subunit, there is clearly an effect on collagenase-3 and OC expression. Studies of OPN in murine melanoma cells demonstrate that treatment of melanoma cells with OPN stimulates expression of another MMP, MMP-2 (also called type IV collagenase or gelatinase A) (83) . In these studies, OPN stimulates expression of MMP-2 and also induces the NF-␤ pathway, which stimulates production of membrane type 1-MMP, and leads to activation of MMP-2. Although the murine melanoma studies represent a different cell line from osteoblasts and show OPN stimulation of MMPs, the studies do demonstrate an additional ability of OPN to regulate MMP expression. Recently, OC levels in OPN-null mice were compared with OC levels in wild type mice (84) . In this study, baseline levels were found to be the same, but when the mice were fed a low calcium diet for 4 weeks and then re-fed a normal diet, the serum OC levels in the normal mice dropped back to baseline, but the serum levels in knockout mice did not respond and remained at high levels. Although little information from that study can be directly related to gene regulation in osteoblasts, it does suggest a change in OC regulation in the absence of OPN in the whole animal.
It has been previously postulated that the production of collagenase-3 by osteoblasts in the late stages of differentiation indicates a phase in bone remodeling where osteoblasts act as bone remodeling cells and degrade bone matrix (44) . The studies presented here suggest an interesting reciprocal mechanism where extracellular proteins and matrix components synthesized by the osteoblast regulate the production of collagenase-3, osteocalcin, and osteopontin. These modes of FIG. 7 . RGD peptidomimetic compound SC65811 stimulates OC and OPN expression and inhibits collagenase-3 expression in differentiating MC3T3-E1 cells. MC3T3-E1 cells were grown to confluence, switched to AA-free ␣-MEM supplemented with 10% FBS, 50 g/ml AA, and 10 mM ␤-gly, and cultured for 1 week in the absence (Ϫ) or presence (SC65811) of 10 M RGD peptidomimetic compound SC65811. Following the 1-week culture period, the cells were lysed and total RNA was examined by Northern analysis with collagenase-3, OC, OPN, and 18 S ribosomal RNA radiolabeled probes using the same blot. A, collagenase-3 normalized to 18 S ribosomal RNA. B, OC normalized to 18 S ribosomal RNA. C, OPN normalized to 18 S ribosomal RNA. *, p Յ 0.011 comparing treatment of the RGD peptidomimetic (SC65811) to the untreated samples (Ϫ) in each group. D, autoradiographs of the same samples used for phosphorimaging quantitation: collagenase-3 (CЈase-3), OC, OPN, and 18 S ribosomal RNA (18S).
regulation could enable the osteoblast to directly participate in feedback mechanisms that influence the growth and remodeling of the surrounding bone matrix. For example, cell signals initiated by OPN during osteoblast differentiation appear to stimulate both OPN and OC expression and inhibit collagenase-3 expression. This mechanism could be viewed as one that promotes mineralization and bone growth as collagenase-3 expression is reduced and both OPN and OC interact with hydroxyapatite. If such a mechanism were stimulated by the action of the RGD peptidomimetic compounds, it could potentially contribute to the bone-sparing activity of these compounds on osteoclasts. Alternatively, the stimulation of OC and OPN expression by OPN could reflect an effort to recruit osteoclasts and stimulate bone resorptive activity. More study on the effects and regulation of OC and collagenase-3 is clearly still needed. cells were grown to confluence, switched to AA-free ␣-MEM supplemented with 10% FBS, 50 g/ml AA, and 10 mM ␤-gly, and cultured for 2 weeks in the absence (Ϫ) or presence of 0.1, 1, or 10 M RGD peptidomimetic compound SC65811. Following the 2-week culture period, the cells were lysed and total RNA was examined by Northern analysis with OC, OPN, and 18 S ribosomal RNA radiolabeled probes using different blots, but the same total RNA samples. A, OC normalized to 18 S ribosomal RNA. B, OPN normalized to 18 S ribosomal RNA.
